Global Phosphodiesterase V Inhibitors Market Research Report 2016

August 2016 | 104 pages | ID: G132DB21097EN
QYResearch

Abstracts

Notes:

Production, means the output of Phosphodiesterase V Inhibitors

Revenue, means the sales value of Phosphodiesterase V Inhibitors

This report studies Phosphodiesterase V Inhibitors in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer, covering

• Actelion Pharmaceuticals Ltd.
• United Therapeutics Corporation
• Gilead sciences
• Bayer AG
• SteadyMed Ltd.
• GlaxoSmithKline plc
• Pfizer Inc.
• Reata Pharmaceuticals Inc.
• Arena Pharmaceuticals Inc.
• Merck & Co. Inc

Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Phosphodiesterase V Inhibitors in these regions, from 2011 to 2021 (forecast), like

• North America
• Europe
• China
• Japan
• Southeast Asia
• India

Split by product type, with production, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by application, this report focuses on consumption, market share and growth rate of Phosphodiesterase V Inhibitors in each application, can be divided into

• Health care
• Clinic
• Hospital

Contents

Global Phosphodiesterase V Inhibitors Market Research Report 2016

1 PHOSPHODIESTERASE V INHIBITORS MARKET OVERVIEW

1.1 Product Overview and Scope of Phosphodiesterase V Inhibitors
1.2 Phosphodiesterase V Inhibitors Segment by Type
  1.2.1 Global Production Market Share of Phosphodiesterase V Inhibitors by Type in 2015
  1.2.2 Type I
  1.2.3 Type II
  1.2.4 Type III
1.3 Phosphodiesterase V Inhibitors Segment by Application
  1.3.1 Phosphodiesterase V Inhibitors Consumption Market Share by Application in 2015
  1.3.2 Health care
  1.3.3 Clinic
  1.3.4 Hospital
1.4 Phosphodiesterase V Inhibitors Market by Region
  1.4.1 North America Status and Prospect (2011-2021)
  1.4.2 Europe Status and Prospect (2011-2021)
  1.4.3 China Status and Prospect (2011-2021)
  1.4.4 Japan Status and Prospect (2011-2021)
  1.4.5 Southeast Asia Status and Prospect (2011-2021)
  1.4.6 India Status and Prospect (2011-2021)
1.5 Global Market Size (Value) of Phosphodiesterase V Inhibitors (2011-2021)

2 GLOBAL PHOSPHODIESTERASE V INHIBITORS MARKET COMPETITION BY MANUFACTURERS

2.1 Global Phosphodiesterase V Inhibitors Production and Share by Manufacturers (2015 and 2016)
2.2 Global Phosphodiesterase V Inhibitors Revenue and Share by Manufacturers (2015 and 2016)
2.3 Global Phosphodiesterase V Inhibitors Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers Phosphodiesterase V Inhibitors Manufacturing Base Distribution, Sales Area and Product Type
2.5 Phosphodiesterase V Inhibitors Market Competitive Situation and Trends
  2.5.1 Phosphodiesterase V Inhibitors Market Concentration Rate
  2.5.2 Phosphodiesterase V Inhibitors Market Share of Top 3 and Top 5 Manufacturers
  2.5.3 Mergers & Acquisitions, Expansion

3 GLOBAL PHOSPHODIESTERASE V INHIBITORS PRODUCTION, REVENUE (VALUE) BY REGION (2011-2016)

3.1 Global Phosphodiesterase V Inhibitors Production and Market Share by Region (2011-2016)
3.2 Global Phosphodiesterase V Inhibitors Revenue (Value) and Market Share by Region (2011-2016)
3.3 Global Phosphodiesterase V Inhibitors Production, Revenue, Price and Gross Margin (2011-2016)
3.4 North America Phosphodiesterase V Inhibitors Production, Revenue, Price and Gross Margin (2011-2016)
3.5 Europe Phosphodiesterase V Inhibitors Production, Revenue, Price and Gross Margin (2011-2016)
3.6 China Phosphodiesterase V Inhibitors Production, Revenue, Price and Gross Margin (2011-2016)
3.7 Japan Phosphodiesterase V Inhibitors Production, Revenue, Price and Gross Margin (2011-2016)
3.8 Southeast Asia Phosphodiesterase V Inhibitors Production, Revenue, Price and Gross Margin (2011-2016)
3.9 India Phosphodiesterase V Inhibitors Production, Revenue, Price and Gross Margin (2011-2016)

4 GLOBAL PHOSPHODIESTERASE V INHIBITORS SUPPLY (PRODUCTION), CONSUMPTION, EXPORT, IMPORT BY REGIONS (2011-2016)

4.1 Global Phosphodiesterase V Inhibitors Consumption by Regions (2011-2016)
4.2 North America Phosphodiesterase V Inhibitors Production, Consumption, Export, Import by Regions (2011-2016)
4.3 Europe Phosphodiesterase V Inhibitors Production, Consumption, Export, Import by Regions (2011-2016)
4.4 China Phosphodiesterase V Inhibitors Production, Consumption, Export, Import by Regions (2011-2016)
4.5 Japan Phosphodiesterase V Inhibitors Production, Consumption, Export, Import by Regions (2011-2016)
4.6 Southeast Asia Phosphodiesterase V Inhibitors Production, Consumption, Export, Import by Regions (2011-2016)
4.7 India Phosphodiesterase V Inhibitors Production, Consumption, Export, Import by Regions (2011-2016)

5 GLOBAL PHOSPHODIESTERASE V INHIBITORS PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

5.1 Global Phosphodiesterase V Inhibitors Production and Market Share by Type (2011-2016)
5.2 Global Phosphodiesterase V Inhibitors Revenue and Market Share by Type (2011-2016)
5.3 Global Phosphodiesterase V Inhibitors Price by Type (2011-2016)
5.4 Global Phosphodiesterase V Inhibitors Production Growth by Type (2011-2016)

6 GLOBAL PHOSPHODIESTERASE V INHIBITORS MARKET ANALYSIS BY APPLICATION

6.1 Global Phosphodiesterase V Inhibitors Consumption and Market Share by Application (2011-2016)
6.2 Global Phosphodiesterase V Inhibitors Consumption Growth Rate by Application (2011-2016)
6.3 Market Drivers and Opportunities
  6.3.1 Potential Applications
  6.3.2 Emerging Markets/Countries

7 GLOBAL PHOSPHODIESTERASE V INHIBITORS MANUFACTURERS PROFILES/ANALYSIS

7.1 Actelion Pharmaceuticals Ltd.
  7.1.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.1.2 Phosphodiesterase V Inhibitors Product Type, Application and Specification
    7.1.2.1 Type I
    7.1.2.2 Type II
  7.1.3 Actelion Pharmaceuticals Ltd. Phosphodiesterase V Inhibitors Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.1.4 Main Business/Business Overview
7.2 United Therapeutics Corporation
  7.2.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.2.2 Phosphodiesterase V Inhibitors Product Type, Application and Specification
    7.2.2.1 Type I
    7.2.2.2 Type II
  7.2.3 United Therapeutics Corporation Phosphodiesterase V Inhibitors Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.2.4 Main Business/Business Overview
7.3 Gilead sciences
  7.3.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.3.2 Phosphodiesterase V Inhibitors Product Type, Application and Specification
    7.3.2.1 Type I
    7.3.2.2 Type II
  7.3.3 Gilead sciences Phosphodiesterase V Inhibitors Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.3.4 Main Business/Business Overview
7.4 Bayer AG
  7.4.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.4.2 Phosphodiesterase V Inhibitors Product Type, Application and Specification
    7.4.2.1 Type I
    7.4.2.2 Type II
  7.4.3 Bayer AG Phosphodiesterase V Inhibitors Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.4.4 Main Business/Business Overview
7.5 SteadyMed Ltd.
  7.5.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.5.2 Phosphodiesterase V Inhibitors Product Type, Application and Specification
    7.5.2.1 Type I
    7.5.2.2 Type II
  7.5.3 SteadyMed Ltd. Phosphodiesterase V Inhibitors Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.5.4 Main Business/Business Overview
7.6 GlaxoSmithKline plc
  7.6.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.6.2 Phosphodiesterase V Inhibitors Product Type, Application and Specification
    7.6.2.1 Type I
    7.6.2.2 Type II
  7.6.3 GlaxoSmithKline plc Phosphodiesterase V Inhibitors Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.6.4 Main Business/Business Overview
7.7 Pfizer Inc.
  7.7.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.7.2 Phosphodiesterase V Inhibitors Product Type, Application and Specification
    7.7.2.1 Type I
    7.7.2.2 Type II
  7.7.3 Pfizer Inc. Phosphodiesterase V Inhibitors Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.7.4 Main Business/Business Overview
7.8 Reata Pharmaceuticals Inc.
  7.8.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.8.2 Phosphodiesterase V Inhibitors Product Type, Application and Specification
    7.8.2.1 Type I
    7.8.2.2 Type II
  7.8.3 Reata Pharmaceuticals Inc. Phosphodiesterase V Inhibitors Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.8.4 Main Business/Business Overview
7.9 Arena Pharmaceuticals Inc.
  7.9.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.9.2 Phosphodiesterase V Inhibitors Product Type, Application and Specification
    7.9.2.1 Type I
    7.9.2.2 Type II
  7.9.3 Arena Pharmaceuticals Inc. Phosphodiesterase V Inhibitors Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.9.4 Main Business/Business Overview
7.10 Merck & Co. Inc
  7.10.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.10.2 Phosphodiesterase V Inhibitors Product Type, Application and Specification
    7.10.2.1 Type I
    7.10.2.2 Type II
  7.10.3 Merck & Co. Inc Phosphodiesterase V Inhibitors Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.10.4 Main Business/Business Overview

8 PHOSPHODIESTERASE V INHIBITORS MANUFACTURING COST ANALYSIS

8.1 Phosphodiesterase V Inhibitors Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Phosphodiesterase V Inhibitors

9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 Phosphodiesterase V Inhibitors Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Phosphodiesterase V Inhibitors Major Manufacturers in 2015
9.4 Downstream Buyers

10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 GLOBAL PHOSPHODIESTERASE V INHIBITORS MARKET FORECAST (2016-2021)

12.1 Global Phosphodiesterase V Inhibitors Production, Revenue Forecast (2016-2021)
12.2 Global Phosphodiesterase V Inhibitors Production, Consumption Forecast by Regions (2016-2021)
12.3 Global Phosphodiesterase V Inhibitors Production Forecast by Type (2016-2021)
12.4 Global Phosphodiesterase V Inhibitors Consumption Forecast by Application (2016-2021)
12.5 Phosphodiesterase V Inhibitors Price Forecast (2016-2021)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
China Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Phosphodiesterase V Inhibitors
Figure Global Production Market Share of Phosphodiesterase V Inhibitors by Type in 2015
Figure Product Picture of Type I
Table Major Manufacturers of Type I
Figure Product Picture of Type II
Table Major Manufacturers of Type II
Figure Product Picture of Type III
Table Major Manufacturers of Type III
Table Phosphodiesterase V Inhibitors Consumption Market Share by Application in 2015
Figure Health care Examples
Figure Clinic Examples
Figure Hospital Examples
Figure North America Phosphodiesterase V Inhibitors Revenue (Million USD) and Growth Rate (2011-2021)
Figure Europe Phosphodiesterase V Inhibitors Revenue (Million USD) and Growth Rate (2011-2021)
Figure China Phosphodiesterase V Inhibitors Revenue (Million USD) and Growth Rate (2011-2021)
Figure Japan Phosphodiesterase V Inhibitors Revenue (Million USD) and Growth Rate (2011-2021)
Figure Southeast Asia Phosphodiesterase V Inhibitors Revenue (Million USD) and Growth Rate (2011-2021)
Figure India Phosphodiesterase V Inhibitors Revenue (Million USD) and Growth Rate (2011-2021)
Figure Global Phosphodiesterase V Inhibitors Revenue (Million UDS) and Growth Rate (2011-2021)
Table Global Phosphodiesterase V Inhibitors Production of Key Manufacturers (2015 and 2016)
Table Global Phosphodiesterase V Inhibitors Production Share by Manufacturers (2015 and 2016)
Figure 2015 Phosphodiesterase V Inhibitors Production Share by Manufacturers
Figure 2016 Phosphodiesterase V Inhibitors Production Share by Manufacturers
Table Global Phosphodiesterase V Inhibitors Revenue (Million USD) by Manufacturers (2015 and 2016)
Table Global Phosphodiesterase V Inhibitors Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Global Phosphodiesterase V Inhibitors Revenue Share by Manufacturers
Table 2016 Global Phosphodiesterase V Inhibitors Revenue Share by Manufacturers
Table Global Market Phosphodiesterase V Inhibitors Average Price of Key Manufacturers (2015 and 2016)
Figure Global Market Phosphodiesterase V Inhibitors Average Price of Key Manufacturers in 2015
Table Manufacturers Phosphodiesterase V Inhibitors Manufacturing Base Distribution and Sales Area
Table Manufacturers Phosphodiesterase V Inhibitors Product Type
Figure Phosphodiesterase V Inhibitors Market Share of Top 3 Manufacturers
Figure Phosphodiesterase V Inhibitors Market Share of Top 5 Manufacturers
Table Global Phosphodiesterase V Inhibitors Production by Regions (2011-2016)
Figure Global Phosphodiesterase V Inhibitors Production and Market Share by Regions (2011-2016)
Figure Global Phosphodiesterase V Inhibitors Production Market Share by Regions (2011-2016)
Figure 2015 Global Phosphodiesterase V Inhibitors Production Market Share by Regions
Table Global Phosphodiesterase V Inhibitors Revenue by Regions (2011-2016)
Table Global Phosphodiesterase V Inhibitors Revenue Market Share by Regions (2011-2016)
Table 2015 Global Phosphodiesterase V Inhibitors Revenue Market Share by Regions
Table Global Phosphodiesterase V Inhibitors Production, Revenue, Price and Gross Margin (2011-2016)
Table North America Phosphodiesterase V Inhibitors Production, Revenue, Price and Gross Margin (2011-2016)
Table Europe Phosphodiesterase V Inhibitors Production, Revenue, Price and Gross Margin (2011-2016)
Table China Phosphodiesterase V Inhibitors Production, Revenue, Price and Gross Margin (2011-2016)
Table Japan Phosphodiesterase V Inhibitors Production, Revenue, Price and Gross Margin (2011-2016)
Table Southeast Asia Phosphodiesterase V Inhibitors Production, Revenue, Price and Gross Margin (2011-2016)
Table India Phosphodiesterase V Inhibitors Production, Revenue, Price and Gross Margin (2011-2016)
Table Global Phosphodiesterase V Inhibitors Consumption Market by Regions (2011-2016)
Table Global Phosphodiesterase V Inhibitors Consumption Market Share by Regions (2011-2016)
Figure Global Phosphodiesterase V Inhibitors Consumption Market Share by Regions (2011-2016)
Figure 2015 Global Phosphodiesterase V Inhibitors Consumption Market Share by Regions
Table North America Phosphodiesterase V Inhibitors Production, Consumption, Import & Export (2011-2016)
Table Europe Phosphodiesterase V Inhibitors Production, Consumption, Import & Export (2011-2016)
Table China Phosphodiesterase V Inhibitors Production, Consumption, Import & Export (2011-2016)
Table Japan Phosphodiesterase V Inhibitors Production, Consumption, Import & Export (2011-2016)
Table Southeast Asia Phosphodiesterase V Inhibitors Production, Consumption, Import & Export (2011-2016)
Table India Phosphodiesterase V Inhibitors Production, Consumption, Import & Export (2011-2016)
Table Global Phosphodiesterase V Inhibitors Production by Type (2011-2016)
Table Global Phosphodiesterase V Inhibitors Production Share by Type (2011-2016)
Figure Production Market Share of Phosphodiesterase V Inhibitors by Type (2011-2016)
Figure 2015 Production Market Share of Phosphodiesterase V Inhibitors by Type
Table Global Phosphodiesterase V Inhibitors Revenue by Type (2011-2016)
Table Global Phosphodiesterase V Inhibitors Revenue Share by Type (2011-2016)
Figure Production Revenue Share of Phosphodiesterase V Inhibitors by Type (2011-2016)
Figure 2015 Revenue Market Share of Phosphodiesterase V Inhibitors by Type
Table Global Phosphodiesterase V Inhibitors Price by Type (2011-2016)
Figure Global Phosphodiesterase V Inhibitors Production Growth by Type (2011-2016)
Table Global Phosphodiesterase V Inhibitors Consumption by Application (2011-2016)
Table Global Phosphodiesterase V Inhibitors Consumption Market Share by Application (2011-2016)
Figure Global Phosphodiesterase V Inhibitors Consumption Market Share by Application in 2015
Table Global Phosphodiesterase V Inhibitors Consumption Growth Rate by Application (2011-2016)
Figure Global Phosphodiesterase V Inhibitors Consumption Growth Rate by Application (2011-2016)
Table Actelion Pharmaceuticals Ltd. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Actelion Pharmaceuticals Ltd. Phosphodiesterase V Inhibitors Production, Revenue, Price and Gross Margin (2011-2016)
Figure Actelion Pharmaceuticals Ltd. Phosphodiesterase V Inhibitors Market Share (2011-2016)
Table United Therapeutics Corporation Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table United Therapeutics Corporation Phosphodiesterase V Inhibitors Production, Revenue, Price and Gross Margin (2011-2016)
Figure United Therapeutics Corporation Phosphodiesterase V Inhibitors Market Share (2011-2016)
Table Gilead sciences Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Gilead sciences Phosphodiesterase V Inhibitors Production, Revenue, Price and Gross Margin (2011-2016)
Figure Gilead sciences Phosphodiesterase V Inhibitors Market Share (2011-2016)
Table Bayer AG Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bayer AG Phosphodiesterase V Inhibitors Production, Revenue, Price and Gross Margin (2011-2016)
Figure Bayer AG Phosphodiesterase V Inhibitors Market Share (2011-2016)
Table SteadyMed Ltd. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table SteadyMed Ltd. Phosphodiesterase V Inhibitors Production, Revenue, Price and Gross Margin (2011-2016)
Figure SteadyMed Ltd. Phosphodiesterase V Inhibitors Market Share (2011-2016)
Table GlaxoSmithKline plc Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table GlaxoSmithKline plc Phosphodiesterase V Inhibitors Production, Revenue, Price and Gross Margin (2011-2016)
Figure GlaxoSmithKline plc Phosphodiesterase V Inhibitors Market Share (2011-2016)
Table Pfizer Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pfizer Inc. Phosphodiesterase V Inhibitors Production, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer Inc. Phosphodiesterase V Inhibitors Market Share (2011-2016)
Table Reata Pharmaceuticals Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Reata Pharmaceuticals Inc. Phosphodiesterase V Inhibitors Production, Revenue, Price and Gross Margin (2011-2016)
Figure Reata Pharmaceuticals Inc. Phosphodiesterase V Inhibitors Market Share (2011-2016)
Table Arena Pharmaceuticals Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Arena Pharmaceuticals Inc. Phosphodiesterase V Inhibitors Production, Revenue, Price and Gross Margin (2011-2016)
Figure Arena Pharmaceuticals Inc. Phosphodiesterase V Inhibitors Market Share (2011-2016)
Table Merck & Co. Inc Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Merck & Co. Inc Phosphodiesterase V Inhibitors Production, Revenue, Price and Gross Margin (2011-2016)
Figure Merck & Co. Inc Phosphodiesterase V Inhibitors Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Phosphodiesterase V Inhibitors
Figure Manufacturing Process Analysis of Phosphodiesterase V Inhibitors
Figure Phosphodiesterase V Inhibitors Industrial Chain Analysis
Table Raw Materials Sources of Phosphodiesterase V Inhibitors Major Manufacturers in 2015
Table Major Buyers of Phosphodiesterase V Inhibitors
Table Distributors/Traders List
Figure Global Phosphodiesterase V Inhibitors Production and Growth Rate Forecast (2016-2021)
Figure Global Phosphodiesterase V Inhibitors Revenue and Growth Rate Forecast (2016-2021)
Table Global Phosphodiesterase V Inhibitors Production Forecast by Regions (2016-2021)
Table Global Phosphodiesterase V Inhibitors Consumption Forecast by Regions (2016-2021)
Table Global Phosphodiesterase V Inhibitors Production Forecast by Type (2016-2021)
Table Global Phosphodiesterase V Inhibitors Consumption Forecast by Application (2016-2021)